- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Infused juice concentrate of Japanese fruit reduces inflammatory remodeling in hypertension
Bainiku-ekisu stopped the inflammatory vascular remodeling and hypertension that Ang II causes, says an article published in Hypertension research. In Japan, fruit from the Prunus mume tree is a staple cuisine. Recently, bainiku-ekisu, a Japanese Prunus mume-infused juice concentrate, has gained popularity as a dietary supplement. Angiotensin II, sometimes known as Ang II, is crucial in the development of hypertension.
A bainiku-ekisu therapy has been shown to reduce the growth-promoting signaling that Ang II causes in vascular smooth muscle cells. It is uncertain, nevertheless, if bainiku-ekisu affects an animal model of hypertension in any way. Therefore, using a mouse model of hypertension with Ang II infusion, Keisuke Okuno and colleagues carried out this investigation to investigate the possible anti-hypertensive efficacy of bainiku-ekisu.
Male C57BL/6 mice were given Ang II injections for two weeks, followed by two weeks of either 0.1% bainiku-ekisu-containing water or regular water, with blood pressure readings. The aortas from the mice that had been put to death after two weeks were taken for examination of remodeling.
The key findings of this study were:
After Ang II infusion, control mice developed aortic medial hypertrophy; this was reduced in the bainiku-ekisu group. Bainiku-ekisu further reduced immune cell infiltration and collagen-producing cell induction in the aorta.
Ang II-induced hypertension's onset was likewise stopped by bainiku-ekisu.
The bainiku-ekisu showed protection against Ang II-induced heart hypertrophy.
In vascular fibroblasts, bainiku-ekisu reduced the activation of vascular cell adhesion molecule-1, an indicator of ER stress, phosphorylation of inositol requiring enzyme-1, and an increase in glucose uptake in response to Ang II.
Reference:
Okuno, K., Torimoto, K., Kuroda, R., Cicalese, S. M., Okuno, Y., Kono, R., Marumoto, S., Utsunomiya, H., & Eguchi, S. (2023). Infused juice concentrate of Japanese plum Prunus mume attenuates inflammatory vascular remodeling in a mouse model of hypertension induced by angiotensin II. In Hypertension Research. Springer Science and Business Media LLC. https://doi.org/10.1038/s41440-023-01332-9
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751